EULAR 2021

COVID-19 Update

Rituximab or JAK inhibitors increase the risk of severe COVID-19

Presented By

Dr Jeffrey Sparks, Brigham and Women’s Hospital, MA, USA

Conference

EULAR 2021

2 August, 2021 23:36

Updates on COVID-19 vaccines in patients with rheumatic disease

Presented By

Dr Victoria Furer, Tel Aviv Sourasky Medical Center, Israel

Conference

EULAR 2021

2 August, 2021 22:44

Immunomodulatory therapies for severe COVID-19: literature update

Presented By

Dr Alessia Alunno, University of Perugia, Italy

Trial

RECOVERY, REMAP-CAP

Conference

EULAR 2021

2 August, 2021 21:50

New Developments in Rheumatoid Arthritis

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By

Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany

Conference

EULAR 2021

2 August, 2021 23:53

Remote management of RA is a feasible alternative for outpatient follow-up

Presented By

Dr Mwidimi Ndosi, University of the West of England, UK

Conference

EULAR 2021

2 August, 2021 22:57

TOVERA: Ultrasound is a promising biomarker of early treatment response

Presented By

Dr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium

Trial

Phase 3, TOVERA

Conference

EULAR 2021

2 August, 2021 21:00

The risks of polypharmacy in RA

Presented By

Dr Soraya Benamar, University Hospital of Montpellier, France

Trial

Cohort study, ESPOIR

Conference

EULAR 2021

2 August, 2021 20:02

ABBV-3373: A potential new therapeutic agent for RA

Presented By

Dr Frank Buttgereit, Charité University Medicine, Germany

Conference

EULAR 2021

2 August, 2021 19:05

JAK inhibitors and bDMARDs show comparable effectiveness

Presented By

Mr Andrei Barbulescu, Karolinska Institutet, Sweden

Conference

EULAR 2021

2 August, 2021 10:23

Spondyloarthritis: Progression in Therapies

SELECT-AXIS: 64-week results of upadacitinib in active ankylosing spondylitis

Presented By

Dr Atul Deodhar, Oregon Health & Science University, OR, USA

Trial

SELECT-AXIS 1

Conference

EULAR 2021

2 August, 2021 23:25

Guselkumab efficacious in PsA patients with inadequate response to TNF inhibition

Presented By

Dr Laura Coates , University of Oxford, UK

Trial

Phase 3, COSMOS

Conference

EULAR 2021

2 August, 2021 22:06

Faecal microbiota transplantation not effective in active peripheral PsA

Presented By

Dr Maja Skov Kragsnaes , University of Southern Denmark, Denmark

Trial

FLORA

Conference

EULAR 2021

2 August, 2021 21:08

Risankizumab meets primary and ranked secondary endpoints in PsA

Presented By

Prof. Andrew Östör, Monash University, Australia

Trial

Phase 3, KEEPsAKE 2

Conference

EULAR 2021

2 August, 2021 20:10

Prognostic factors for minimal disease activity in early psoriatic arthritis revealed

Presented By

Prof. Tatiana Korotaeva, Nasonova Research Institute of Rheumatology, Russia

Conference

EULAR 2021

2 August, 2021 18:13

Imaging in Large-Vessel Vasculitis

PET/CT is a reliable measure of disease activity in LVV, but does not predict future relapses

Presented By

Dr Elena Galli , University of Modena and Reggio Emilia, Italy

Conference

EULAR 2021

2 August, 2021 23:14

Ultrasound is useful for disease monitoring in giant cell arteritis

Presented By

Dr Cristina Ponte, Hospital de Santa Maria Lisbon, Portugal

Conference

EULAR 2021

2 August, 2021 22:19

Prevention in Rheumatic Diseases

Gene-Environment Interaction in Gout

Gene-diet and gene-weight interactions associated with the risk of gout

Presented By

Dr Chio Yokose, Massachusetts General Hospital, USA

Conference

EULAR 2021

2 August, 2021 23:26

What Is New in Systemic Lupus Erythematosus

Juvenile Idiopathic Arthritis and Osteoarthritis

Efficacy and safety of secukinumab in juvenile idiopathic arthritis

Presented By

Dr Nicola Ruperto, IRCCS Istituto G. Gaslini, Italy

Trial

Phase 3, JUNIPERA

Conference

EULAR 2021

2 August, 2021 23:33

Emerging therapies and future treatment directions in osteoarthritis

Presented By

Prof. Xavier Chevalier, University Paris-Est Créteil, France

Trial

FORWARD, CANTOS

Conference

EULAR 2021

2 August, 2021 18:35